Results 11 to 20 of about 1,735 (146)

高龄急性轻型缺血性卒中早期阿替普酶静脉溶栓疗效观察 Observation of the Effect of Alteplase Intravenous Thrombolysis in the Early Stage of Acute Mild Ischemic Stroke in the Elderly

open access: yesZhongguo cuzhong zazhi, 2018
目的 探讨高龄轻型缺血性卒中3 h内行阿替普酶静脉溶栓治疗的疗效及安全性。 方法 将我院2015年10月-2017年10月连续收治入院的发病3 h内48例高龄急性轻型缺血性卒中患者 随机分为阿替普酶静脉溶栓组24例和未溶栓组24例。比较两组患者入院时的一般情况,基线美国 国立卫生研究院卒中量表(National Institutes of Health Stroke Scale,NHISS)评分,治疗24 h后颅内出 血转化率,治疗后90 d改良Rankin量表(modified Rankin ...
杨江胜,朱祖福,高志强,陆强彬,周国庆,方琪
doaj   +1 more source

A case of Brucella Cases Analysis and Discussion [PDF]

open access: yes, 2017
临床药师参与1例布鲁氏菌病感染常规方案治疗无效患者的临床诊断与治疗全过程,通过参与医生查房、病例讨论等提出自己意见,对提高诊治水平、优化治疗方案、合理使用抗菌药物起到了推动作用,最终患者好转并出院.为明确布鲁氏菌病诊断,促进临床合理用药累积了宝贵的经验.Clinical pharmacists participated in treatment of 1 cases of brucellosis infection which conventional treatment was invalid ...
林清江, 魏吟秋, 黄阅欣
core   +1 more source

Integrated traditional Chinese and Western medicine nursing for a patient with acute myocardial infarction with chest pain as the chief complaint (1例急性心肌梗死胸痛患者的中西医结合护理体会)

open access: yes中西医结合护理, 2023
This paper summarized the integrated traditional Chinese and Western medicine nursing for a patient with acute myocardial infarction with chest pain as the chief complaint. The thrombolytic therapy was conducted after comprehensive evaluation of pain and
MA Shanshan (马珊珊)   +5 more
doaj   +1 more source

发病3h DWI阴性的后循环梗死1例:基底动脉过度弯曲并血栓形成及文献复习 [PDF]

open access: yes
Objective: The role of the basilar artery morphological abnormalities (BAMA) in the pathogenesis of posterior circulation infarction (PCI) was summarized and analyzed based on the main line of the diagnosis and treatment of the basilar artery excessive ...
Chi, Xiang-Lin, Yu, Yong-peng
core   +2 more sources

缺血性卒中静脉溶栓后症状性颅内出血研究进展 Progress of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Ischemic Stroke

open access: yesZhongguo cuzhong zazhi, 2018
出血转化,尤其症状性颅内出血是缺血性卒中患者急性期静脉溶栓后虽不常见但严重的 并发症,其致残率和病死率均较高,严重影响患者预后。我国卒中急性期溶栓率远远落后于欧美国 家,临床医生担心出血转化风险是主要原因。本文对溶栓后症状性颅内出血进行综述,以提高临床 认识,更好地改进卒中急性期溶栓治疗。 Abstract: Bleeding transformation, especially symptomatic intracranial hemorrhage is an uncommon but ...
梁志刚,杨绍婉,于国平
doaj   +1 more source

ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识 [PDF]

open access: yes, 2018
急性心肌梗死仍然严重威胁我国人民健康,在我国广大城乡地区,形势更为严峻[1,2]。及时救治急性心肌梗死患者,降低死亡率和保护心脏功能刻不容缓。鉴于我国的实际情况,院前溶栓治疗在大城市以外的城乡地区具有重要意义。为此,中国医师协会胸痛专业委员会及中国医学救援协会心血管急救分会专门组织有关专家制订了本共识 ...
于海玲   +23 more
core  

Critical Left Ventricular Ejection Fraction and Its Possible Pathogenesis in STEMI Patients with Supra-normal Ejection Fraction after Primary PCI [PDF]

open access: yes, 2022
BackgroundLeft ventricular ejection fraction (LVEF) is often used as an assessment indicator for left ventricular systolic function. As adverse events occur in some patients with preserved LVEF, other phenotypes based on LVEF may exist in the population ...
HAO Xiao, ZHAO Mei, LI Shuren
core   +1 more source

重组组织型纤溶酶原激活剂静脉治疗轻型缺血性卒中患者的疗效分析 Efficacy and Safety of Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator in Acute Mild#br# Ischemic Stroke

open access: yesZhongguo cuzhong zazhi, 2018
目的 观察轻型缺血性卒中患者重组组织型纤溶酶原激活剂(recombinant tissue plasminogen activator,rt-PA)静脉溶栓治疗的疗效及安全性。 方法 收集2016年1月-2017年9月轻型缺血性卒中患者共166例作为研究对象,根据发病后有无接受 rt-PA静脉溶栓治疗将患者分为溶栓组及对照组。比较两组溶栓后24 h和7 d时美国国立卫生研究院 卒中量表(National Institutes of Health stroke scale,NIHSS)评分、90 ...
于若梅, 曹谡涵, 毛保义, 杨西, 陶梦醒, 孙晓培
doaj   +1 more source

The Role of SRC-1 in myocardial infarction [PDF]

open access: yes, 2016
类固醇激素受体辅激活子(steroidreceptorcoactivator,SRC)作为一类转录协同因子,能够与多种转录因子相互作用并增强其转录活性。SRC-1是SRC家族(SRC-1/NCoA-1、SRC-2/GRIP/TIF2、SRC-3/AIB1/ACTR/pCTP/RAC3/TRAM-1)的一员。已有的研究表明SRC-1在体内具有多种生物学功能,SRC-1可参与乳腺癌、前列腺癌、肝癌等多种癌症的增殖与入侵。SRC-1在脑内突触的可塑性、神经干细胞分化等生理过程具有重要调控作用。此外,SRC ...
占少鹏
core  

Ethanol‐Lock Therapy for the Prevention of Central Venous Access Device Infections in Pediatric Patients With Intestinal Failure [PDF]

open access: yes, 2011
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/141158/1/jpen0067.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/141158/2/jpen0067-sup-0001 ...
Anagnostopoulos D   +36 more
core   +1 more source

Home - About - Disclaimer - Privacy